Abstract
In the present study, a series of 4-(1-aryl-5-chloro-2-oxo-1,2-dihydro-indol-3-ylideneamino)-N-substituted benzene sulfonamides (1–20) was synthesized and screened for their in vitro antimicrobial activity against Gram positive, Gram negative bacterial and fungal strains indicating that compound 19 (N-(4-(5-Bromo-1-(4-chlorobenzoyl)-2-oxoindolin-3-ylideneamino)phenylsulfonyl)-4-isopropoxybenzamide) was found to be the most active antimicrobial agent. The anticancer activity of synthesized compounds against mouse leukemic monocyte macrophage cell line (RAW 264.7) and colon cancer (HCT116) cell lines indicated that compound 16 (4-(5-Bromo-1-(4-chlorobenzoyl)-2-oxoindolin-3-ylideneamino)-N-(4,6-dimethylpyrimidin-2-yl)benzene sulfonamide) was found to be the most potent cytotoxic agent against HCT116 and compounds 17 (4-(5-Bromo-1-(4-chlorobenzoyl)-2-oxoindolin-3-ylideneamino)-N-(6-methoxypyridazin-3-yl)benzene sulfonamide) and 19 (N-(4-(5-Bromo-1-(4-chlorobenzoyl)-2-oxoindolin-3-ylideneamino)phenylsulfonyl)-4-isopropoxybenzamide) were found to be the most potent cytotoxic agents against RAW264.7 cancer cell lines.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
